Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse

Biomarkers are needed to address overtreatment that occurs for the majority of prostate cancer patients that would not die of the disease but receive radical treatment. A possible barrier to biomarker discovery may be the polyclonal/multifocal nature of prostate tumors as well as cell-type heterogen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jia, Zhenyu, Rahmatpanah, Farah B., Chen, Xin, Lernhardt, Waldemar, Wang, Yipeng, Xia, Xiao-Qin, Sawyers, Anne, Sutton, Manuel, McClelland, Michael, Mercola, Dan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2012
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3411675/
https://ncbi.nlm.nih.gov/pubmed/22870216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0041371
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge